標(biāo)題: Titlebook: Behavioral Clinical Trials for Chronic Diseases; Scientific Foundatio Lynda H. Powell,Kenneth E. Freedland,Peter G. Kauf Book 2021 Springer [打印本頁] 作者: tricuspid-valve 時間: 2025-3-21 19:13
書目名稱Behavioral Clinical Trials for Chronic Diseases影響因子(影響力)
書目名稱Behavioral Clinical Trials for Chronic Diseases影響因子(影響力)學(xué)科排名
書目名稱Behavioral Clinical Trials for Chronic Diseases網(wǎng)絡(luò)公開度
書目名稱Behavioral Clinical Trials for Chronic Diseases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Behavioral Clinical Trials for Chronic Diseases被引頻次
書目名稱Behavioral Clinical Trials for Chronic Diseases被引頻次學(xué)科排名
書目名稱Behavioral Clinical Trials for Chronic Diseases年度引用
書目名稱Behavioral Clinical Trials for Chronic Diseases年度引用學(xué)科排名
書目名稱Behavioral Clinical Trials for Chronic Diseases讀者反饋
書目名稱Behavioral Clinical Trials for Chronic Diseases讀者反饋學(xué)科排名
作者: ligature 時間: 2025-3-21 23:25
Lynda H. Powell,Kenneth E. Freedland,Peter G. KaufFirst comprehensive book on basic principles in the design and conduct of behavioral RCTs aimed at preventing or managing chronic diseases.Aims to promote same level of rigor in behavioral RCTs that i作者: consolidate 時間: 2025-3-22 01:12 作者: 暴行 時間: 2025-3-22 07:23
Immunotoxin Treatment of Brain Tumorsoral treatments. This book aims to increase the quality of evidence for the value of behavioral treatments for the prevention and management of chronic diseases. It presents the scientific foundations of clinical trials, a progressive translational model for treatment development, and the integratio作者: 確定的事 時間: 2025-3-22 09:53
https://doi.org/10.1007/978-1-4613-1083-9the development of evidence for the value of behavioral treatments that meets the standards for quality that exist in medicine. Evidence for quality is strongest in . efficacy trials which follow the agreed-upon “rules” for clinical trial methods. In the behavioral clinical trial literature, there a作者: Truculent 時間: 2025-3-22 13:47
Edward J. Wawrzynczak,Philip E. Thorpetanding, evolving, and widely accepted process of drug development. It then draws on basic elements of this process to present the revised ORBIT model for developing behavioral treatments for chronic diseases. This model pushes toward . behavioral efficacy testing in three progressive phases: (1) . 作者: 套索 時間: 2025-3-22 17:07
How protein toxins enter and kill cellsd a treatment to improve human health, it is called a clinical trial. The great philosophers of science argued that a good scientific hypothesis “sticks its neck out” with a quantified prediction which can only be tested in an experiment that is free of bias. They further argued that failure should 作者: 同來核對 時間: 2025-3-22 21:27 作者: CROW 時間: 2025-3-23 01:45 作者: FLASK 時間: 2025-3-23 06:33 作者: HUMP 時間: 2025-3-23 12:04 作者: Organonitrile 時間: 2025-3-23 14:58 作者: gusher 時間: 2025-3-23 20:46 作者: 改正 時間: 2025-3-24 01:00
Schriftenreihe Neurologie‘ Neurology Seriesls will replace the “one-size-fits all” approach to behavioral trial design with designs that feature a progression of questions, a progression of methods, and the use of guidelines to facilitate decision-making. Behavioral treatments will produce stronger effects with the emergence of precision lif作者: endoscopy 時間: 2025-3-24 06:05 作者: Intractable 時間: 2025-3-24 09:41
Epilogue,ion and management of chronic diseases. It is a guide to the science, strategies, methods, and processes that produce the data needed to close the gap between discovery and uptake in clinical practice.作者: 異端邪說下 時間: 2025-3-24 13:37
https://doi.org/10.1007/978-3-030-39330-4behavioral randomized clinical trials; clinically significant behavioral health benefit; clinically si作者: 光滑 時間: 2025-3-24 15:38
Springer Nature Switzerland AG 2021作者: 健談 時間: 2025-3-24 20:51
Introduction,oral treatments. This book aims to increase the quality of evidence for the value of behavioral treatments for the prevention and management of chronic diseases. It presents the scientific foundations of clinical trials, a progressive translational model for treatment development, and the integratio作者: CAB 時間: 2025-3-25 02:25
Quality of a Clinical Trial,the development of evidence for the value of behavioral treatments that meets the standards for quality that exist in medicine. Evidence for quality is strongest in . efficacy trials which follow the agreed-upon “rules” for clinical trial methods. In the behavioral clinical trial literature, there a作者: 包庇 時間: 2025-3-25 07:21 作者: HAWK 時間: 2025-3-25 08:35 作者: Antarctic 時間: 2025-3-25 14:51 作者: Sputum 時間: 2025-3-25 18:20
The Choice of a Comparator,one-size-fits-all” comparator that controls for non-specific treatment factors. The recent emergence of frameworks for comparator choice aims to create explicit rules which place a priority on the primary purpose of the trial within its developmental context. This chapter reviews implicit and explic作者: Oafishness 時間: 2025-3-25 19:58 作者: intoxicate 時間: 2025-3-26 02:00
Protection of Random Assignment,eatment and undermines the ability to make causal inferences. This chapter focuses on why random assignment is so powerful and should be protected. It presents a history of attempts to answer the question of whether or not a treatment works, and the arrival at random assignment as the best way to ma作者: 木訥 時間: 2025-3-26 05:42 作者: 大看臺 時間: 2025-3-26 08:50 作者: innate 時間: 2025-3-26 14:18 作者: Glutinous 時間: 2025-3-26 18:31
Epilogue,ion and management of chronic diseases. It is a guide to the science, strategies, methods, and processes that produce the data needed to close the gap between discovery and uptake in clinical practice.作者: 桶去微染 時間: 2025-3-26 23:30 作者: 危機(jī) 時間: 2025-3-27 02:49
Outcomes, clinical relevance are characteristics of outcome assessment in confirmatory behavioral trials. Exploration of moderators, mediators, and mechanisms are more appropriate for earlier stages of behavioral treatment development.作者: Scintillations 時間: 2025-3-27 06:00 作者: Occupation 時間: 2025-3-27 09:33 作者: Offensive 時間: 2025-3-27 14:40 作者: fixed-joint 時間: 2025-3-27 19:04
https://doi.org/10.1007/978-1-4613-1083-9re many more . than . trials. What is needed is not a larger quantity of such evidence, but a higher quality of evidence using the standards that exist in medicine. This book applies a progressive, translational science model to achieve that goal.作者: SHRIK 時間: 2025-3-27 22:30 作者: 手工藝品 時間: 2025-3-28 04:05
Edward J. Wawrzynczak,Philip E. Thorpestudies, feasibility studies, and . behavioral trials with behavioral and biomedical outcomes. Recommendations for fostering translational behavioral treatment research are suggested for funding agencies, publication practices, and investigators.作者: mighty 時間: 2025-3-28 07:48 作者: Lipohypertrophy 時間: 2025-3-28 13:41 作者: 外星人 時間: 2025-3-28 15:56
Behavioral Treatment Development,studies, feasibility studies, and . behavioral trials with behavioral and biomedical outcomes. Recommendations for fostering translational behavioral treatment research are suggested for funding agencies, publication practices, and investigators.作者: rectum 時間: 2025-3-28 22:01
The Choice of a Comparator,ose as understanding of a behavioral treatment progresses, prioritize purpose over logistic and scientific limitations of any particular comparator, and raise caution about the danger of choosing a comparator that inadvertently changes the purpose of the trial.作者: 盟軍 時間: 2025-3-29 00:33 作者: 泥土謙卑 時間: 2025-3-29 03:52 作者: 美學(xué) 時間: 2025-3-29 11:00 作者: outset 時間: 2025-3-29 11:41
